{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:22:24Z","timestamp":1790320944422,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ejca.2010.04.009","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T16:52:07Z","timestamp":1273769527000},"page":"2225-2234","source":"Crossref","is-referenced-by-count":100,"title":["Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy"],"prefix":"10.1016","volume":"46","author":[{"given":"Bj\u00f8rn H.","family":"Gr\u00f8nberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Sundstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Kaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Bremnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fl\u00f8tten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Amundsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald H.","family":"Hjelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian von","family":"Plessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Jordh\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2010.04.009_bib1","doi-asserted-by":"crossref","unstructured":"Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 2008;26:4617\u201325.","DOI":"10.1200\/JCO.2008.17.7162"},{"key":"10.1016\/j.ejca.2010.04.009_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.lungcan.2008.05.003","article-title":"Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States","volume":"63","author":"Lang","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2010.04.009_bib4","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8","article-title":"Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma","volume":"92","author":"Sweeney","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2010.04.009_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2407-9-130","article-title":"Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials","volume":"9","author":"Vardy","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2010.04.009_bib6","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1200\/JCO.2004.02.175","article-title":"Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US food and drug administration","volume":"22","author":"Talarico","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0169-5002(98)00039-7","article-title":"Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study","volume":"21","author":"Janssen-Heijnen","year":"1998","journal-title":"Lung cancer"},{"key":"10.1016\/j.ejca.2010.04.009_bib8","unstructured":"Cancer Registry of Norway. Cancer in Norway 2007 \u2013 Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2008."},{"key":"10.1016\/j.ejca.2010.04.009_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0360-3016(01)02741-9","article-title":"Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer","volume":"52","author":"Firat","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2010.04.009_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0360-3016(02)02939-5","article-title":"Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group","volume":"54","author":"Firat","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2010.04.009_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1040-8428(00)00090-1","article-title":"Measurement and impact of comorbidity in older cancer patients","volume":"35","author":"Extermann","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2010.04.009_bib12","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1200\/JCO.2004.08.040","article-title":"Differential prognostic impact of comorbidity","volume":"22","author":"Read","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2007.12.8322","article-title":"Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials","volume":"26","author":"Asmis","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/annonc\/mdn064","article-title":"Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients","volume":"19","author":"Jacot","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib15","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1200\/JCO.2005.02.527","volume":"23","author":"Maione","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1179\/joc.2005.17.6.685","article-title":"Gemcitabine and cisplatin in the treatment of elderly patients with advanced non-small cell lung cancer: impact of comorbidities on safety and efficacy outcome","volume":"17","author":"Moscetti","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.ejca.2010.04.009_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.archger.2008.01.011","article-title":"Predictors of treatment failures during chemotherapy: a prospective study on 110 older cancer patients","volume":"48","author":"Marinello","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.ejca.2010.04.009_bib18","unstructured":"Gr\u00f8nberg BH, Bremnes RM, Fl\u00f8tten \u00d8, et al. Phase III study by the Norwegian Lung Cancer Study Group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol, in press."},{"key":"10.1016\/j.ejca.2010.04.009_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1532-5415.1968.tb02103.x","article-title":"Cumulative illness rating scale","volume":"16","author":"Linn","year":"1968","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.ejca.2010.04.009_bib20","unstructured":"Miller MD, Towers A. A manual for guidelines for scoring the cumulative illness rating scale for geriatrics (CIRS-G). University of Pittsburgh, May 1991."},{"key":"10.1016\/j.ejca.2010.04.009_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0959-8049(99)00319-6","article-title":"Measuring comorbidity in older cancer patients","volume":"36","author":"Extermann","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2010.04.009_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1986.4.5.702","article-title":"Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study","volume":"4","author":"Finkelstein","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","article-title":"The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours","volume":"2","author":"Goldstraw","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01243894-200606000-00011","article-title":"Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594","volume":"1","author":"Wakelee","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1378\/chest.125.1.27","article-title":"Smoking and lung cancer survival: the role of comorbidity and treatment","volume":"125","author":"Tammemagi","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ejca.2010.04.009_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01243894-200610000-00010","article-title":"Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?","volume":"1","author":"Sundstrom","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejca.2004.10.017","article-title":"Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group","volume":"41","author":"Osoba","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2010.04.009_bib28","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1001\/archinte.148.12.2561","article-title":"The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation","volume":"148","author":"Talcott","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejca.2010.04.009_bib29","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2010.04.009_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.otohns.2008.05.027","article-title":"The effect of comorbidity on quality of life during radiotherapy in head and neck cancer","volume":"139","author":"Oozeer","year":"2008","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804910003126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804910003126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:02:08Z","timestamp":1559091728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804910003126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0959804910003126"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2010.04.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}